Rubicon Research's Q2 FY 2025-26 Quarterly Results
- 16 Nov 2025
Result Summary
- Rubicon Research Ltd reported a 15.6% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a - of -.
- Its expenses for the quarter were up by 14.7% QoQ and - - YoY.
- The net profit increased 24.4% QoQ and - - YoY.
- The earnings per share (EPS) of Rubicon Research Ltd stood at 3.47 during Q2 FY 2025-26.
Financial Statments for Q2 FY 2025-26
Total Income | 412.72 | 356.94 | 0.00 | 15.6% | - |
Total Expenses | 341.01 | 297.39 | 0.00 | 14.7% | - |
Profit Before Tax | 71.70 | 59.56 | - | 20.4% | NaN% |
Tax | 17.85 | 16.26 | 0.00 | 9.8% | - |
Profit After Tax | 53.85 | 43.30 | 0.00 | 24.4% | - |
Earnings Per Share | 3.47 | 2.79 | 0.00 | 24.4% | - |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Rubicon Research Ltd is a company that operates within the pharmaceutical sector, focusing on research and development in drug delivery technologies. The company is known for its innovative approach towards formulating pharmaceutical products and its commitment to advancing healthcare solutions. As of the information available up to October 2023, there are no specific recent major developments publicly disclosed for Rubicon Research Ltd. Therefore, any further insights into recent corporate activities or strategic directions are not available.
Revenue
In the second quarter of the fiscal year 2026 (Q2FY26), Rubicon Research Ltd reported a total income of ₹412.72 crores. This marks a quarter-over-quarter (QoQ) increase of 15.6% compared to the previous quarter (Q1FY26), where the total income was ₹356.94 crores. Year-over-year (YoY) comparison is not available due to missing data from the same quarter in the previous fiscal year (Q2FY25). This growth in total income indicates an upward trajectory in revenue generation within the reported period.
Profitability
The profitability of Rubicon Research Ltd showed a positive movement in Q2FY26, with the Profit Before Tax (PBT) amounting to ₹71.70 crores, reflecting a 20.4% increase QoQ from ₹59.56 crores in Q1FY26. The Profit After Tax (PAT) was ₹53.85 crores in Q2FY26, representing a 24.4% QoQ increase from ₹43.30 crores in Q1FY26. The Earnings Per Share (EPS) also increased by 24.4% QoQ, from ₹2.79 in Q1FY26 to ₹3.47 in Q2FY26. The tax expense for Q2FY26 was ₹17.85 crores, up 9.8% QoQ from ₹16.26 crores in Q1FY26. The year-over-year comparison for these figures is not available due to the absence of comparable data from Q2FY25.
Operating Metrics
Operating metrics for Rubicon Research Ltd in Q2FY26 indicate a total expense of ₹341.01 crores, which shows a 14.7% increase QoQ from ₹297.39 crores in Q1FY26. The increase in expenses is slightly lower than the increase in total income, contributing to improved profitability metrics for the quarter. Year-over-year data for operating expenses is not available for comparison. The company’s ability to manage its expenses in relation to its growing income is a key factor in its operational performance for the quarter.